Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion

Zi, Wenjie; Song, Jiaxing; Kong, Weilin; Huang, Jiacheng; Guo, Changwei; He, Wencheng; Yu, Yinquan; Zhang, Bo; Geng, Wanjie; Tan, Xiaolin; Tian, Yaoyu; Liu, Zongtao; Cao, Minghua; Cheng, Daoyou; Li, Bo; Huang, Wenguo; Liu, Junsheng; Wang, Pengfei; Zhou, Yu; Liang, Hao; Yang, Shuang; Tang, Mingshan; Liu, Wenhua; Huang, Xianjun; Liu, Shugai; Tang, Yufeng; Wu, Youlin; Li, Yao; Shi, Zhu; He, Pengcheng; Zhao, Haojin; Chen, Zhuo; Luo, Jun; Wan, Yue; Shi, Qiang; Wang, Maorong; Yang, De; Chen, Xianglin; Huang, Fang; Mu, Jinlin; Li, Hao; Li, Zhimin; Zheng, Jingbang; Xie, Shunli; Cai, Tieying; Peng, Yuqi; Xie, Weihua; Qiu, Zhongming; Liu, Chang; Yue, Chengsong; Li, Linyu; Tian, Yan; Yang, Dahong; Miao, Jian; Yang, Jie; Hu, Jinrong; G. Nogueira, Raul; Wang, Duolao; L. Saver, Jeffrey; Li, Fengli; Yang, Qingwu

doi:10.1056/nejmoa2214299

Public

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion

Published in New England Journal of Medicine • May 31, 2023

Authors:

Wenjie Zi

Jiaxing Song

Weilin Kong

Abstract

BACKGROUND: The effects of the glycoprotein IIb/IIIa receptor inhibitor tirofiban in patients with acute ischemic stroke but who have no evidence of complete occlusion of large or medium-sized vessels have not been extensively studied. METHODS: In a multicenter trial in China, we enrolled patients w...

Subject

Medicine

Tirofiban

Thrombolysis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!